Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chinese Herbal Medicines is Scopus-indexed (Q1, CiteScore 13.5), WoS ESCI. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 1674-6384Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Complementary and Alternative Medicine | 1 / 115 | 99th | Q1 |
| Pharmacology (medical) | 12 / 278 | 95th | Q1 |
| Pharmacology | 20 / 328 | 94th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas
Yes — actively indexed in Scopus, coverage 2018–present (also 2016, 2012), best quartile Q1, CiteScore 13.5.
Chinese Herbal Medicines is Q1 in Complementary and Alternative Medicine (rank 1 of 115), Q1 in Pharmacology (medical) (rank 12 of 278) and Q1 in Pharmacology (rank 20 of 328), by CiteScore 2025.
Chinese Herbal Medicines is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 13.5, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.456, quartile Q1, with an H-index of 33.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$1,200 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Chinese Herbal Medicines is published by Elsevier B.V. Its ISSN is 1674-6384.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal per Scopus.
Chinese Herbal Medicines has an h-index of 41 and a 2-year mean of 3.87 citations per paper (OpenAlex). Its Scopus CiteScore is 13.5, quartile Q1. On 2-year citations it ranks #14 of 109 Scopus journals in Complementary and Alternative Medicine.
Chinese Herbal Medicines published 72 papers in 2025; its busiest recent year was 2023 with 79. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2025–2026), authors are most often from China (82.3%), United States (3.4%) and Macao SAR China (1.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.